A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Over the last decade, the field of cancer metabolism has mainly focused on studying the role of tumorigenic metabolic rewiring in supporting cancer proliferation. Here, we perform the first genome‐scale computational study of the metabolic underpinnings of cancer migration. We build genome‐scale metabolic models of the NCI ‐60 cell lines that capture the Warburg effect (aerobic glycolysis) typically occurring in cancer cells. The extent of the Warburg effect in each of these cell line models is quantified by the ratio of glycolytic to oxidative ATP flux ( AFR ), which is found to be highly positively associated with cancer cell migration. We hence predicted that targeting genes that mitigate the Warburg effect by reducing the AFR may specifically inhibit cancer migration. By testing the anti‐migratory effects of silencing such 17 top predicted genes in four breast and lung cancer cell lines, we find that up to 13 of these novel predictions significantly attenuate cell migration either in all or one cell line only, while having almost no effect on cell proliferation. Furthermore, in accordance with the predictions, a significant reduction is observed in the ratio between experimentally measured ECAR and OCR levels following these perturbations. Inhibiting anti‐migratory targets is a promising future avenue in treating cancer since it may decrease cytotoxic‐related side effects that plague current anti‐proliferative treatments. Furthermore, it may reduce cytotoxic‐related clonal selection of more aggressive cancer cells and the likelihood of emerging resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403
Global reconstruction of the human metabolic network based on genomic and bibliomic data
Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., Srivas, R., & Palsson, B. Ø. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610772104 · Cited by 1,374
Integrating high-throughput and computational data elucidates bacterial networks
Covert, M. W., Knight, E. M., Reed, J. L., Herrgard, M. J., & Palsson, B. O. (2004) · Nature · doi:10.1038/nature02456 · Cited by 792
Network-based prediction of human tissue-specific metabolism
Shlomi, T., Cabili, M. N., Herrgård, M. J., Palsson, B. Ø., & Ruppin, E. (2008) · Nature Biotechnology · doi:10.1038/nbt.1487 · Cited by 637
Self-citationHaem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase
Frezza, C., Zheng, L., Folger, O., Rajagopalan, K. N., MacKenzie, E. D., Jerby, L., Micaroni, M., Chaneton, B., Adam, J., Hedley, A., et al. (2011) · Nature · doi:10.1038/nature10363 · Cited by 503 · cited 1×
“…of cancer cells have been reconstructed and applied for predicting selective drug targets, as well as for studying the role of tumor suppressors and oxidative stress (Folger et al , 2011; Frezza et al , 2011; Agren et al , 2012, 2014; Jerby et al , 2012; Goldstein et al , 2013; Gatto et al , 2014).”
BackgroundSelf-citationThe Edinburgh human metabolic network reconstruction and its functional analysis
Ma, H., Sorokin, A., Mazein, A., Selkov, A., Selkov, E., Demin, O., & Goryanin, I. (2007) · Molecular Systems Biology · doi:10.1038/msb4100177 · Cited by 435 · cited 1×
“Over the last few years, GSMMs have been successfully used for modeling human metabolism as well (Duarte et al , 2007; Ma et al , 2007; Shlomi et al , 2008; Gille et al , 2010; Lewis et al , 2010; Mardinoglu et al , 2013).”
MethodMultidimensional Optimality of Microbial Metabolism
Schuetz, R., Zamboni, N., Zampieri, M., Heinemann, M., & Sauer, U. (2012) · Science · doi:10.1126/science.1216882 · Cited by 420 · cited 1×
“…, 2009; Chandrasekaran & Price, 2010; Jensen & Papin, 2010; Szappanos et al , 2011; Wessely et al , 2011; Lerman et al , 2012; Nogales et al , 2012; Schuetz et al , 2012) including drug discovery (Trawick & Schilling, 2006; Oberhardt et al , 2013; Yizhak et al , 2013) and metabolic engineering…”
BackgroundDetailing the optimality of photosynthesis in cyanobacteria through systems biology analysis
Nogales, J., Gudmundsson, S., Knight, E. M., Palsson, B. O., & Thiele, I. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117907109 · Cited by 301 · cited 1×
“…(Oberhardt et al , 2009; Chandrasekaran & Price, 2010; Jensen & Papin, 2010; Szappanos et al , 2011; Wessely et al , 2011; Lerman et al , 2012; Nogales et al , 2012; Schuetz et al , 2012) including drug discovery (Trawick & Schilling, 2006; Oberhardt et al , 2013; Yizhak et al , 2013) and…”
Background
Research works printed but not linked: 42
- Agren R, Bordel S, Mardinoglu A, Pornputtapong N, Nookaew I, Nielsen J (2012) Reconstruction of genome‐scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comput Biol 8: e1002518 · DOI · Paper page
- Agren R, Mardinoglu A, Asplund A, Kampf C, Uhlen M, Nielsen J (2014) Identification of anticancer drugs for hepatocellular carcinoma through personalized genome‐scale metabolic modeling. Mol Syst Biol 10: 721 · DOI · Paper page
- Burgard AP, Pharkya P, Maranas CD (2003) Optknock: a bilevel programming framework for identifying gene knockout strategies for microbial strain optimization. Biotechnol Bioeng 84: 647–657 · DOI · Paper page
- Chandrasekaran S, Price ND (2010) Probabilistic integrative modeling of genome‐scale metabolic and regulatory networks in Escherichia coli and Mycobacterium tuberculosis. Proc Natl Acad Sci 107: 17845–17850 · DOI · Paper page
- Chang HY, Nuyten DSA, Sneddon JB, Hastie T, Tibshirani R, Sørlie T, Dai H, He YD, van't Veer LJ, Bartelink H, van de Rijn M, Brown PO, van de Vijver MJ (2005) Robustness, scalability, and integration of a wound‐response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A 102: 3738–3743 · DOI · Paper page
- Cheong H, Lu C, Lindsten T, Thompson CB (2012) Therapeutic targets in cancer cell metabolism and autophagy. Nat Biotechnol 30: 671–678 · DOI · Paper page
- Choy E, Yelensky R, Bonakdar S, Plenge RM, Saxena R, De Jager PL, Shaw SY, Wolfish CS, Slavik JM, Cotsapas C, Rivas M, Dermitzakis ET, Cahir‐McFarland E, Kieff E, Hafler D, Daly MJ, Altshuler D (2008) Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines. PLoS Genet 4: e1000287 · DOI · Paper page
- Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamaría G, Kim H, Zapata JM, Marusawa H, Chamorro M, Reed JC (2002) The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res 62: 6674–6681
- De Bock K, Georgiadou M, Schoors S, Kuchnio A, Wong Brian W, Cantelmo Anna R, Quaegebeur A, Ghesquière B, Cauwenberghs S, Eelen G, Phng L‐K, Betz I, Tembuyser B, Brepoels K, Welti J, Geudens I, Segura I, Cruys B, Bifari F, Decimo I et al (2013) Role of PFKFB3‐driven glycolysis in vessel sprouting. Cell 154: 651–663 · DOI · Paper page
- Ezratty EJ, Partridge MA, Gundersen GG (2005) Microtubule‐induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase. Nat Cell Biol 7: 581–590 · DOI · Paper page
- Folger O, Jerby L, Frezza C, Gottlieb E, Ruppin E, Shlomi T (2011) Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol 7: 501 · DOI · Paper page
- Förster R, Schubel A, Breitfeld D, Kremmer E, Renner‐Müller I, Wolf E, Lipp M (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99: 23–33 · DOI · Paper page
- Gatto F, Nookaew I, Nielsen J (2014) Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma. Proc Natl Acad Sci 111: E866–E875 · DOI · Paper page
- Gille C, Bolling C, Hoppe A, Bulik S, Hoffmann S, Hubner K, Karlstadt A, Ganeshan R, Konig M, Rother K, Weidlich M, Behre J, Holzhutter H‐G (2010) HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology. Mol Syst Biol 6: 411 · DOI · Paper page
- Goldstein I, Yizhak K, Madar S, Goldfinger N, Ruppin E, Rotter V (2013) p53 promotes the expression of gluconeogenesis‐related genes and enhances hepatic glucose production. Cancer Metab 1: 9 · DOI · Paper page
- Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646–674 · DOI · Paper page
- Hirschhaeuser F, Sattler UGA, Mueller‐Klieser W (2011) Lactate: a metabolic key player in cancer. Cancer Res 71: 6921–6925 · DOI · Paper page
- Jensen PA, Papin JA (2010) Functional integration of a metabolic network model and expression data without arbitrary thresholding. Bioinformatics 27: 541–547 · DOI · Paper page
- Jerby L, Wolf L, Denkert C, Stein GY, Hilvo M, Oresic M, Geiger T, Ruppin E (2012) Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer Res 72: 5712–5720 · DOI · Paper page
- Lee JK, Havaleshko DM, Cho H, Weinstein JN, Kaldjian EP, Karpovich J, Grimshaw A, Theodorescu D (2007) A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery. Proc Natl Acad Sci 104: 13086–13091 · DOI · Paper page
- Lewis NE, Schramm G, Bordbar A, Schellenberger J, Andersen MP, Cheng JK, Patel N, Yee A, Lewis RA, Eils R, Konig R, Palsson BO (2010) Large‐scale in silico modeling of metabolic interactions between cell types in the human brain. Nat Biotechnol 28: 1279–1285 · DOI · Paper page
- Mardinoglu A, Agren R, Kampf C, Asplund A, Nookaew I, Jacobson P, Walley AJ, Froguel P, Carlsson LM, Uhlen M, Nielsen J (2013) Integration of clinical data with a genome‐scale metabolic model of the human adipocyte. Mol Syst Biol 9: 649 · DOI · Paper page
- Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, Pawitan Y, Hall P, Klaar S, Liu ET, Bergh J (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 102: 13550–13555 · DOI · Paper page
- Oberhardt MA, Palsson BO, Papin JA (2009) Applications of genome‐scale metabolic reconstructions. Mol Syst Biol 5: 320 · DOI · Paper page
- Oberhardt MA, Yizhak K, Ruppin E (2013) Metabolically re‐modeling the drug pipeline. Curr Opin Pharmacol 13: 778–785 · DOI
- Penault‐Llorca F, André F, Sagan C, Lacroix‐Triki M, Denoux Y, Verriele V, Jacquemier J, Baranzelli MC, Bibeau F, Antoine M, Lagarde N, Martin A‐L, Asselain B, Roché H (2009) Ki67 expression and docetaxel efficacy in patients with estrogen receptor‐positive breast cancer. J Clin Oncol 27: 2809–2815 · DOI · Paper page
- Pharkya P, Burgard AP, Maranas CD (2004) OptStrain: a computational framework for redesign of microbial production systems. Genome Res 14: 2367–2376 · DOI · Paper page
- Price ND, Reed JL, Palsson BO (2004) Genome‐scale models of microbial cells: evaluating the consequences of constraints. Nat Rev Microbiol 2: 886–897 · DOI · Paper page
- Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR (2003) Cell migration: integrating signals from front to back. Science 302: 1704–1709 · DOI · Paper page
- van Roosmalen W, Le Dévédec SE, Zovko S, de Bont H, van de Water B (2011) Functional screening with a live cell imaging‐based random cell migration assay. Methods Mol Biol 769: 435–448 · doi:10.1007/978-1-61779-207-6_29
- Sarrio D, Rodriguez‐Pinilla SM, Hardisson D, Cano A, Moreno‐Bueno G, Palacios J (2008) Epithelial‐mesenchymal transition in breast cancer relates to the basal‐like phenotype. Cancer Res 68: 989–997 · DOI · Paper page
- Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO, Weinstein JN (2000) A gene expression database for the molecular pharmacology of cancer. Nat Genet 24: 236–244 · DOI · Paper page
- Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, Khvorova A, Brugge JS (2008) Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol 10: 1027–1038 · DOI · Paper page
- Szappanos B, Kovacs K, Szamecz B, Honti F, Costanzo M, Baryshnikova A, Gelius‐Dietrich G, Lercher MJ, Jelasity M, Myers CL, Andrews BJ, Boone C, Oliver SG, Pal C, Papp B (2011) An integrated approach to characterize genetic interaction networks in yeast metabolism. Nat Genet 43: 656–662 · DOI · Paper page
- Trawick JD, Schilling CH (2006) Use of constraint‐based modeling for the prediction and validation of antimicrobial targets. Biochem Pharmacol 71: 1026–1035 · DOI
- Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029–1033 · DOI · Paper page
- Vincent‐Salomon A, Rousseau A, Jouve M, Beuzeboc P, Sigal‐Zafrani B, Fréneaux P, Rosty C, Nos C, Campana F, Klijanienko J, Al Ghuzlan A, Sastre‐Garau X (2004) Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline‐based preoperative chemotherapy. Eur J Cancer 40: 1502–1508 · DOI
- Warburg O (1956) On the origin of cancer cells. Science 123: 309–314 · DOI · Paper page
- Wessely F, Bartl M, Guthke R, Li P, Schuster S, Kaleta C (2011) Optimal regulatory strategies for metabolic pathways in Escherichia coli depending on protein costs. Mol Syst Biol 7: 515 · DOI · Paper page
- Wu M, Neilson A, Swift AL, Moran R, Tamagnine J, Parslow D, Armistead S, Lemire K, Orrell J, Teich J, Chomicz S, Ferrick DA (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292: C125–C136 · DOI · Paper page
- Yizhak K, Gabay O, Cohen H, Ruppin E (2013) Model‐based identification of drug targets that revert disrupted metabolism and its application to aging. Nat Commun 4: 2632 · DOI
- Zhang Y, Moerkens M, Ramaiahgari S, de Bont H, Price L, Meerman J, van de Water B (2011) Elevated insulin‐like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes. Breast Cancer Res 13: R52 · DOI · Paper page
Cited by
Systems analysis of intracellular pH vulnerabilities for cancer therapy
Persi, E., Duran-Frigola, M., Damaghi, M., Roush, W. R., Aloy, P., Cleveland, J. L., Gillies, R. J., & Ruppin, E. (2018) · Nature Communications · doi:10.1038/s41467-018-05261-x · Cited by 406
Self-citationThe gut microbiota modulates host amino acid and glutathione metabolism in mice
Mardinoglu, A., Shoaie, S., Bergentall, M., Ghaffari, P., Zhang, C., Larsson, E., Bäckhed, F., & Nielsen, J. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156487 · Cited by 383
Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways
Jia, D., Lu, M., Jung, K. H., Park, J. H., Yu, L., Onuchic, J. N., Kaipparettu, B. A., & Levine, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816391116 · Cited by 336
Yu, L., Lu, M., Jia, D., Ma, J., Ben-Jacob, E., Levine, H., Kaipparettu, B. A., & Onuchic, J. N. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2074 · Cited by 272
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities
Lanning, N. J., Castle, J. P., Singh, S. J., Leon, A. N., Tovar, E. A., Sanghera, A., MacKeigan, J. P., Filipp, F. V., & Graveel, C. R. (2017) · Cancer & Metabolism · doi:10.1186/s40170-017-0168-x · Cited by 175
Metadata
- Authors
- Yizhak, K., Le Dévédec, S. E., Rogkoti, V. M., Baenke, F., de Boer, V. C., Frezza, C., Schulze, A., van de Water, B., & Ruppin, E.
- Venue
- Molecular Systems Biology
- Published
- 2014-08
- Volume
- 10
- Issue
- 8
- Pages
- 744-744
- ISSN
- 1744-4292 (ISSN-L)
- OpenAlex
- W2152027903
- Cited by
- 139
- References
- 13
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Update notices
- addendum (2014-11-28)
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- Edmond J. Safra Bioinformatics center at Tel‐Aviv University
- Azrieli Foundation
- Netherlands Consortium for Systems Biology
- EU FP7 Systems Microscopy NoE project (258068)
- Netherlands Genomics Initiative
- Israeli Science Foundation
- Israeli Cancer Research Fund
- I‐CORE Program of the Planning and Budgeting Committee (41/11)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration. https://app.cochat.ai/papers/10.15252/msb.20134993
- The paper
- Yizhak, K., Le Dévédec, S. E., Rogkoti, V. M., Baenke, F., de Boer, V. C., Frezza, C., Schulze, A., van de Water, B., & Ruppin, E. (2014). A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration. Molecular Systems Biology. https://doi.org/10.15252/msb.20134993
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.